Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression

Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression

Ibnu Purwanto,1,* Benedreky Leo,2,* Susanna Hilda Hutajulu,1 Johan Kurnianda,1 Kartika Widayati Taroeno-Hariadi,1 Mardiah Suci Hardianti,1 Amanda Dania Satiti,1 Ery Kus Dwianingsih,3 Didik Setyo Heriyanto,3 Irianiwati Widodo,3 Teguh Aryandono4 1Division of Hematology and Medical Onco...

Full description

Bibliographic Details
Main Authors: Purwanto I, Leo B, Hutajulu SH, Kurnianda J, Taroeno-Hariadi KW, Hardianti MS, Satiti AD, Dwianingsih EK, Heriyanto DS, Widodo I, Aryandono T
Format: Article
Language:English
Published: Dove Medical Press 2023-07-01
Series:Breast Cancer: Targets and Therapy
Subjects:
vimentin
p53 mutant
chemotherapy
platinum resistance
tnbc
prognostic factor
Online Access:https://www.dovepress.com/prognostic-value-of-vimentin-in-triple-negative-breast-cancer-patients-peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/prognostic-value-of-vimentin-in-triple-negative-breast-cancer-patients-peer-reviewed-fulltext-article-BCTT

Similar Items